Markets · 1 sources covering this

A failed trial for a heart drug casts shadow over rivals developing similar therapies

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·2h ago
A failed trial for a heart drug casts shadow over rivals developing similar therapies
The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/0994c50ce6c1b40887be3e01606e3db78dcc8f8d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="A failed trial for a heart drug casts shadow over rivals developing similar therapies"></iframe>

A failed trial for a heart drug casts shadow over rivals developing similar therapies

How 1 sources are covering this

A failed trial for a heart drug casts shadow over rivals developing similar therapies

More from Markets

This retired professor has reinvented himself — as a Taylor Swift scholar

Japan Household Outlays Fall Most Since Pandemic

Australia’s Consumer Confidence Slumps on Cost-of-Living Fears

Colombian Inflation Accelerates Less Than Forecast to 6.30%

Reader

Trust & legal

Across the network

How 1 sources are covering this

A failed trial for a heart drug casts shadow over rivals developing similar therapies

More from Markets

This retired professor has reinvented himself &#x2014; as a Taylor Swift scholar

Japan Household Outlays Fall Most Since Pandemic

Australia’s Consumer Confidence Slumps on Cost-of-Living Fears

Colombian Inflation Accelerates Less Than Forecast to 6.30%

Reader

Trust & legal

Across the network

This retired professor has reinvented himself — as a Taylor Swift scholar